Abstract
Malnutrition is a known complication of chronic GVHD (cGVHD), but has not been well described in the context of organ-specific manifestations and the recent National Institutes of Health (NIH) criteria. Here, 210 cGVHD patients were analyzed, in a cross-sectional study design, for demographics, transplant-related history, clinical assessments, symptoms, function, quality-of-life, laboratory values and survival in order to determine their associations with nutritional status. Most patients had long-standing, moderate or severe cGVHD and had failed many lines of therapy. Twenty-nine percent (60/210) of subjects were malnourished, using the subjective Patient-Generated Subjective Global Assessment (PG-SGA) questionnaire and evaluation. No demographic or transplant characteristics were associated with malnutrition; cGVHD of the lungs, gastrointestinal (GI) tract and mouth, NIH global score, cGVHD symptoms, worse functioning, low albumin, poorer survival and low BMI were associated with malnutrition. A predictive model was developed from all variables of significance: cGVHD of the lungs, GI tract, mouth and BMI accurately predicted 84.2% of malnourished patients as well as 87.2% of well-nourished patients. The PG-SGA questionnaire may be a useful tool in diagnosing nutritional deficits in cGVHD patients undergoing one-time evaluations. Longitudinal prospective studies should assess the utility of nutritional support interventions in cGVHD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrara J, Levine J, Reddy P, Holler E . Graft-versus-host disease. Lancet 2009; 373: 1550–1561.
Syrjala K, Martin P, Lee S . Delivering care to long-term adult survivors of hematopoietic cell transplantation. J Clin Oncol 2012; 30: 3746–3751.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Jacobsohn D, Margolis J, Doherty J, Anders V, Vogelsang G . Weight loss and malnutrition in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 231–236.
Nixon DW, Heymsfield SB, Cohen AE, Kutner MH, Ansley J, Lawson DH . Protein-calorie undernutrition in hositalized cancer patients. Am J Med 1980; 68: 683–690.
Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR . Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 1995; 15: 461–468.
Kyle U, Chalandon Y, Miralbell R, Karsegard V, Hans D, Trombetti A et al. Longitudinal follow-up of body composition in hematopoietic stem cell transplant patinets. Bone Marrow Transplant 2005; 35: 1171–1177.
Gupta D, Vashi P, Lammersfeld C, Braun D . Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature. Ann Nutr Metab 2011; 59: 96–106.
Bauer J, Capra S, Ferguson M . Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutritional tool in patients with cancer. Eur J Clin Nutr 2002; 56: 779–785.
Leuenberger M, Kurmann S, Stanga Z . Nutritional screening tools in daily clinical practice: the focus on cancer. Support Care Cancer 2010; S2: 17–27.
Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant 2006; 12: 252–266.
Lee S, Cook E, Soiffer R, Antin J . Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444–452.
Davidson M, Morton Nd . A Systematic review of the Human Activity Profile. Clin Rehabil 2007; 21: 151–162.
Ware J, Gandek B . Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol 1998; 51: 903–912.
McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–368.
Mitchell S, Leidy N, Mooney K, Dudley W, Beck S, LaStayo P et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant 2010; 45: 762–769.
Pidala J, Kurland B, Chai X, Majhail N, Weisdorf D, Pavletic S et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the chronic GVHD consortium. Blood 2011; 117: 5651–4657.
Herzberg P, Heussner P, Mumm F, Horak M, Hilgendorf I, Harsdorf Sv et al. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16: 707–1717.
Mehta C, Patel N . A network algorithm for performing Fisher’s exact test in r x c contingency tables. J Am Stat Assoc 1983; 78: 427–434.
Agresti A . Categorical Data Analysis. John Wiley and Sons Inc: New York, NY, USA, 1990.
Grkovic L, Baird K, Steinberg S, Williams K, Pulanic D, Cowen E et al. Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia 2012; 26: 633–643.
Grkovic L, Mitchell SA, Baird K, Steinberg SM, Cowen EW, Williams KM et al. Assessing the validity of the NIH response criteria for chronic graft-versus-host disease (cGVHD): consensus measures correlate with clinical outcomes. Blood. 2011; 118: Abstract 4074.
Roberts S, Thompson J . Graft-vs-host disease: nutrition therapy in a clinically challening condition. Nutr Clin Pract 2005; 20: 440–450.
Lenssen P, Sherry ME, Cheney CL, Nims JW, Sullivan KM, Stern JM et al. Prevalence of nutrition-related problems among long-term survivers of allogeneic marrow transplantation. J Am Diet Assoc 1990; 90: 835–842.
Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC . Oral graft-versus-host disease. Oral Dis 2008; 14: 396–412.
Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW et al. Salivary gland involvement in chronic graft-versus-host disease: Prevalence, clinical significance, and recommendations for evaluations. Biol Blood Marrow Transplant 2010; xxx: 1–8.
Fall-Dickson JM, Mitchell SA, Marden S, Ramsay ES, Guadagnini JP, Wu T et al. Oral symtom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 948–956.
Lenssen P . Hematopoietic cell transplantation: Contemporary Nutrition Support Practice. Saunders Co.: St. Louis, MO, USA, 2003.
Stosovic M, Naumovic R, Stanojevic M, Simic-Ogrizovic S, Jovanovic D, Djukanovic L . Could the level of serum albumin be a method for assessing malnutrition in hemodialysis patients? Nutr Clin Pract 2011; 26: 607–613.
Martin PJ, Inamoto Y, Carpenter PA, Lee SJ, Flowers ME . Treatment of chronic graft-versus-host disease: past, present and future. Korean J Hematol 2011; 46: 153–163.
Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006; 12: 491–505.
Acknowledgements
This study was funded by the intramural programs of the National Cancer Institute, Center for Cancer Research and the National Institute of Dental and Craniofacial Research, as well as by the other intramural programs of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Bassim, C., Fassil, H., Dobbin, M. et al. Malnutrition in patients with chronic GVHD. Bone Marrow Transplant 49, 1300–1306 (2014). https://doi.org/10.1038/bmt.2014.145
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.145
This article is cited by
-
Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial
Bone Marrow Transplantation (2024)
-
The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT
Bone Marrow Transplantation (2023)
-
Impact of Resistance Exercise and Nutritional Endorsement on physical performance in patients with GvHD (IRENE-G study) – design and rational of a randomized controlled trial
BMC Cancer (2022)
-
Nutrition Support Practices of Hematopoietic Stem Cell Transplantation Centers in Mainland China
Current Medical Science (2020)
-
Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease
Journal of Cancer Research and Clinical Oncology (2020)